TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
12,156
|
0 |
Financial expenses |
2,785
|
11,044
|
176 |
Earnings before taxes |
-339,194
|
-559,015
|
-35,801 |
EBITDA |
-338,528
|
-549,072
|
-36,014 |
Total assets |
90,898
|
197,901
|
14,295 |
Current assets |
47,602
|
142,537
|
11,386 |
Current liabilities |
71,225
|
170,419
|
2,400 |
Equity capital |
19,673
|
27,482
|
11,895 |
- share capital |
2,696
|
2,703
|
243 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.6%
|
13.9%
|
83.2% |
Turnover per employee |
0
|
6,078
|
0 |
Profit as a percentage of turnover | -4598.7% | ||
Return on assets (ROA) |
-370.1%
|
-276.9%
|
-249.2% |
Current ratio |
66.8%
|
83.6%
|
474.4% |
Return on equity (ROE) |
-1724.2%
|
-2034.1%
|
-301.0% |
Change turnover |
-12,156
|
12,156
|
0 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0%
|
100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.